Pages that link to "Q37928902"
Jump to navigation
Jump to search
The following pages link to Proteinuria and hypertension with tyrosine kinase inhibitors. (Q37928902):
Displaying 19 items.
- Multikinase inhibitors use in differentiated thyroid carcinoma. (Q34660901) (← links)
- SFlt-1 elevates blood pressure by augmenting endothelin-1-mediated vasoconstriction in mice. (Q35121861) (← links)
- Cardiac side effects of anticancer treatments: new mechanistic insights (Q36957758) (← links)
- Value of Foxp3 expressing T-regulatory cells in renal tissue in lupus nephritis; an immunohistochemical study (Q37127975) (← links)
- Angiotensin II increases glomerular permeability by β-arrestin mediated nephrin endocytosis (Q37526033) (← links)
- Nephrotic syndrome associated with tyrosine kinase inhibitors for pediatric malignancy: case series and review of the literature (Q38169098) (← links)
- Hypertension Induced by Tyrosine-Kinase Inhibitors for the Treatment of Renal Cell Carcinoma in Hemodialysis Patients: A Single-Center Experience and Review of the Literature. (Q39330209) (← links)
- Focused Ultrasound-Triggered Release of Tyrosine Kinase Inhibitor From Thermosensitive Liposomes for Treatment of Renal Cell Carcinoma. (Q40346197) (← links)
- Long- and short-term treatment with imatinib attenuates the development of chronic kidney disease in experimental anti-glomerular basement membrane nephritis (Q44464485) (← links)
- Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis (Q46305857) (← links)
- Successful treatment of a metastatic, gastrointestinal stromal tumour in a dog with toceranib phosphate (Palladia). (Q47859487) (← links)
- Effects of Toceranib Phosphate on the Hypothalamic-Pituitary-Thyroid Axis in Tumor-Bearing Dogs. (Q48202305) (← links)
- Guidelines for treatment of renal injury during cancer chemotherapy 2016. (Q50063006) (← links)
- Summary of the 2018 ISN Frontiers Meeting: Kidney Disease and Cardiovascular Disease. (Q55476169) (← links)
- Pazopanib, Cabozantinib, and Vandetanib in the Treatment of Progressive Medullary Thyroid Cancer with a Special Focus on the Adverse Effects on Hypertension (Q57808230) (← links)
- Navigating Systemic Therapy in Advanced Thyroid Carcinoma: From Standard of Care to Personalized Therapy and Beyond (Q58784257) (← links)
- Effects of Antiangiogenetic Drugs on Microcirculation and Macrocirculation in Patients with Advanced-Stage Renal Cancer (Q61811842) (← links)
- Targeting angiogenesis and lymphangiogenesis in kidney disease (Q90119264) (← links)
- A retrospective study of proteinuria in dogs receiving toceranib phosphate (Q94046670) (← links)